Abstract The mechanism of cellular uptake by endocytosis and subsequent oxidative stress has been identified as the paradigm for the toxic response of cationically surface charged nanoparticles. In an attempt to circumvent the process, the effect of increased cellular membrane permeability on the uptake mechanisms of poly(amidoamine) dendrimers generations 4 (G4) and 6 (G6) in vitro was investigated. Immortalised, non-cancerous human keratinocyte (HaCaT) cells were treated with DL-buthionine-(S,R)-sulfoximine (BSO). Active uptake of the particles was monitored using fluorescence microscopy to identify and quantify endosomal activity and resultant oxidative stress, manifested as increased levels of reactive oxygen species, monitored using the carboxy-H 2 DCFDA dye. Dose-dependent cytotoxicity for G4 and G6 exposure was registered using the cytotoxicity assays Alamar Blue and MTT, from 6 to 72 h. Reduced uptake by endocytosis is observed for both dendrimer species. A dramatic change, compared to untreated cells, is observed in the cytotoxic and oxidative stress response of the BSO-treated cells. The significantly increased mitochondrial activity, dosedependent antioxidant behaviour and reduced degree of endocytosis for both dendrimer generations, in BSO-treated cells, indicate enhanced permeability of the cell membrane, resulting in the passive, diffusive uptake of dendrimers, replacing endocytosis as the primary uptake mechanism. The complex MTT response reflects the importance of glutathione in maintaining redox balance within the mitochondria. The study highlights the importance of regulation of this redox balance for cell metabolism but also points to the potential of controlling the nanoparticle uptake mechanisms, and resultant cytotoxicity, with implications for nanomedicine.
Introduction
Nanoparticle science is a rapidly advancing field which holds much promise in areas such as targeted drug and gene delivery [1] [2] [3] . However, nanoparticle uptake into a cell has been demonstrated, particularly for nanoparticles with an effective cationic surface charge, to give rise to cytotoxic responses, raising concerns about the potential health and environmental impact of the proliferation of nanomaterials in consumer products [4] . A systematic understanding of the mechanisms of toxicity and their dependence on nanoparticle physicochemical properties on a cellular level is therefore required [5] . In the context of nanomedical applications, understanding and controlling the uptake process and subcellular trafficking of the delivery vehicle and the bioavailability of the cargo are critically important.
Cellular uptake of nanoparticles principally occurs via endocytosis, whereby the nanoparticle is invaginated by the cellular membrane and is transported into the cell [6] . As the low pH environment of the endosome attempts to digest the nanoparticle, the redox balance of the cell is disrupted, and in the case of nanoparticles with an effective cationic surface charge, the process gives rise to an increase in the production of reactive oxygen species (ROS), localised mainly around the endosome (or later lysosome) [6] [7] [8] [9] . Although intracellular antioxidants attempt to neutralise the imbalance, ROS production can be sufficient to lead to oxidative stress [10] . Subsequently, a cascade of events and the release of several characteristic cytokines and chemokines occur, ultimately leading to cell death, a process which is the accepted paradigm of nanotoxicity of many nanoparticles in vitro [6] . The process has been well demonstrated for model nanoparticle system such as amine functionalised polystyrene [11] [12] [13] , amorphous nanosilica [14] and nanomeric polymeric dendrimers [10] .
Aminated molecules are intrinsic antioxidants, however, and generally regarded as ROS scavengers. As examples, spermine and spermidine have both been shown to reduce Fe 3+ to Fe 2+ [15] and the ferric reducing activity of these molecules has been identified as a measure of antioxidant potential [16] . Carnosine, an endogenous dipeptide, has been shown to scavenge both reactive oxygen and nitrogen species [17] . Notably, in a study by Khalid et al., while the larger, higher generations of the aminated nanoscale dendrimers poly(propylene imine) (PPI) were demonstrated to elicit oxidative stress and significant toxicity, the smaller, lower generations exhibited intracellular antioxidant behaviour and low toxicity [18] . Examination of the uptake mechanisms indicated a transition from cellular uptake by passive diffusion at low generations to active endocytosis for higher generations. The study suggests that, in the case of catatonically charge nanoparticles, the endocytotic uptake and trafficking process is, in itself, a source of cellular toxicity. In the context of drug delivery, invagination of the delivery vehicle and cargo in this harsh environment may also be undesirable, and although escape by endosomolysis is a potential strategy [19] , this too can be a harsh process, causing significant damage to the cell [20, 21] . For these reasons, circumventing endocytosis appears to be a valid strategy for the reduction of toxicity associated with aminated nanoparticles as well as nanoparticle drug or gene delivery.
Guarnieri et al. demonstrated that functionalization of aminated polystyrene nanoparticles with the viral peptide gH625 (derived from Herpes simplex virus -1), which has a membrane perturbing domain, enables translocation of particles to the cytoplasm, avoiding endocytosis and thus dramatically reducing the cytotoxicity [22] . An alternative strategy to increase the permeability of the cellular membrane, in vitro, is through the application of DL-buthionine-(S,R)-sulfoximine (BSO). BSO has previously been employed to study the effects of the reduction of levels of the intracellular antioxidant glutathione (GSH) and therefore oxidative stress [23] [24] [25] [26] and has been shown to cause membrane permeabilisation [27, 28] . BSO works as an inhibitor of the enzyme glutamate cysteine ligase (EC 6.3.2.2) (historically known as gammaglutamylcysteine synthetase) which is the first step in the production of GSH in the cell [29] . This reduction in GSH causes several different effects, one being the induction of the membrane permeability transition in the mitochondria [30] [31] [32] . The opening of this pore and the depletion of GSH allow ROS to diffuse from the mitochondria to the cell and via lipid peroxidation, cause damage to the cell membrane [28] , leading to increased permeability.
The reduction of GSH in the cell can have other adverse effects, however, mainly due to the fact that GSH is one of the main antioxidants involved in maintaining the redox balance of the mitochondria [33] . In the mitochondria, endogenous ROS is produced as a by-product of normal metabolism, and therefore, completely eliminating GSH can leave the cell susceptible to damage from this ROS [34] . Furthermore, reductions in cellular GSH can also lead to changes in the regulation of Ca 2+ distribution [35] [36] [37] and the activation/deactivation of signalling pathways involved with growth, differentiation and apoptosis [33, [38] [39] [40] . The loss of GSH and subsequent changes in the cell have been implicated in several disease states which is reviewed elsewhere [34] .
This study explores the impact, for HaCaT cells, of BSO treatment on the cellular uptake of, and subsequent oxidative stress and toxic response to, poly(amidoamine) (PAMAM) dendrimers. These nanoscale aminated dendrimers have a systematically variable molecular structure, and the homologous series of increasing generation, and concomitant size and number of surface amino groups, has been demonstrated to be ideal to study the dependence of nanoparticle cellular interactions on the physico-chemical properties of the particles. Previous studies have examined the structurally dependent toxicity and underlying mechanisms of endocytosis, oxidative stress, immune responses and consequent toxicity [7] [8] [9] [10] , and the responses have been numerically modelled, as a guide towards a predictive toxicology approach [10, 41] . For consistency and to allow comparisons with the previous work, the in vitro studies reported here were also carried out using the immortalised human keratinocyte cell line, HaCaT, and identical oxidative stress and cytotoxic assays. Furthermore, PAMAM dendrimers of generations 4 and 6 were chosen as the extremes of the previously reported cytotoxicological response [7] [8] [9] [10] . In comparison, it is demonstrated that treatment with BSO results in a significant change in the nanoparticle uptake mechanisms and cytotoxicity.
Materials and methods

Materials
DMEM F12 HAM growth medium, penicillin, streptomycin, fluorescently labelled polystyrene nanoparticles with amine surface modification (PSNP-NH 2 ) 100 nm, BSO and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) dye were purchased from Sigma-Aldrich, Ireland. The PAMAM dendrimer nanoparticles, generations 4 (molecular weight 14,214 g/mol) and 6 (molecular weight 58,046 g/mol), were purchased from Sigma-Aldrich and manufactured by Dendritech Inc. ThiolTracker™ Violet (TTV), CellLight® Early Endosomes-RFP, BacMam 2.0, fetal bovine serum (FBS), L-glutamine, Alamar Blue (AB) and 5-(and-6)-carboxy-2′,7′-dichlorodihydrofluorescein diacetate (carboxy-H 2 DCFDA) dye were purchased from Life Technologies™, Bio-Sciences, Ireland. HaCaT cells were purchased from Cell Line Services (CLS), Eppelheim, Germany. TrueLine 96-well cell culture plates were used for all viability and ROS studies.
All fluorescence and absorbance readings were taken on a Molecular Devices SpectraMax M3 spectrometer. Confocal laser scanning fluorescence microscopy (CLSM) images were taken on a Zeiss LSM 510 confocal laser scanning microscope and processed using ImageJ software (with co-localisation analysis performed with the JaCoP plugin for ImageJ). All viability, ROS and GSH data analysis was performed using SigmaPlot v10.0 software.
Methods
Cell culture
HaCaT cells are an immortalised, non-cancerous human keratinocyte cell line and were used for these experiments. The cells were cultured in DMEM F12 HAM supplemented with 10 % FBS, 45 IU/mL penicillin, 45 IU/mL streptomycin and 2 mM L-glutamine at 37°C in 5 % CO 2 .
All assays carried out in this set of experiments were performed in 96-well plates, with cells plated at a concentration of 1 × 10 4 cells/well in 100 μL of DMEM medium. Cells were allowed 24 h to attach and were then treated with BSO for an additional 18 h (at a concentration of 200 μM), after which cells were exposed to PAMAM G4 or G6 dendrimers (in DMEM F12 HAM, with 5 % FBS, 45 IU/mL penicillin, 45 IU/mL streptomycin, 2 mM L-glutamine and 200 μM BSO) at various concentrations for the specified time points. Six replicates of each concentration were performed per plate and each plate was repeated in triplicate.
ThiolTracker™ Violet
TTV is a GSH detection agent. Cells were plated as described above and a concentration gradient of BSO was applied. Cells were left for 18 h at 37°C in 5 % CO 2 to allow for reduction of the amount of intracellular GSH. Cells were then washed twice with PBS, 100 μL of TTV dye (at a final concentration of 20 μM) was added to each well and the plates were allowed to incubate at 37°C in 5 % CO 2 for 30 min, after which the TTV solution was removed and replaced with PBS. The fluorescence of each well was then read using the SpectraMax M3 spectrometer with λ EX = 404 nm and λ EM = 526 nm. GSH values were calculated as compared to the unexposed control.
Viability assays
Alamar Blue and MTT assays were used to determine the changes in cell viability, after treatment with BSO as described above, as a result of exposure to both PAMAM G4 and G6 dendrimers. Both Alamar Blue and MTT were performed on the same plate. The PAMAM G4 concentrations used were 0.16, 0.32, 0.65, 1.3, 2.6, 5.2, 7.8 and 10.4 μM, while the PAMAM G6 concentrations were 0.08, 0.16, 0.32, 0.65, 1.3, 2.6, 3.9 and 5.2 μM. The lower initial value of the PAMAM G6 dendrimers was used due to their reported EC 50 value being much lower than their G4 counterparts [7] [8] [9] . Dosedependent viability percentages were calculated at time points 6, 12, 24, 48 and 72 h. Percentage viability was calculated as compared to a control which had been exposed to 200 μM BSO but had no nanoparticle treatment; this was to ensure that any changes were caused by the nanoparticle and were not the result of BSO treatment. A separate control where no BSO was present was also performed and showed that there was little difference between cells with no BSO exposure and cells which were exposed to BSO (Electronic Supplementary Material (ESM), Fig. S1 ).
Alamar Blue
The Alamar Blue assay was made up from 10× stock solution in medium (DMEM F12 HAM, with no additional supplements). At the specified time point, the plates were removed from the incubator and the medium containing PAMAM dendrimer was removed, the cells were washed with 100 μL PBS and then 100 μL of DMEM F12 HAM (unsupplemented) containing Alamar Blue was added to each well. The plates were incubated for 3 h at 37°C in 5 % CO 2 to allow for conversion of the dye. The fluorescence of each well was then read using the SpectraMax M3 spectrometer with λ EX = 555 nm and λ EM = 585 nm.
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
A stock solution of MTT was made at a concentration of 0.5 mg/mL, and 500 μL of this stock was added for every 10 mL of medium (DMEM F12 HAM, with no additional supplements). At the specified time point, the plates were removed from the incubator and the medium containing PAMAM dendrimer was discarded, the cells were washed w i t h 1 0 0 μ L PBS and then 100 μ L of DMEM (unsupplemented) containing MTT was added to each well. The plates were incubated for 3 h at 37°C in 5 % CO 2 to allow for conversion of the dye. After 3 h, any remaining dye was removed and each well was again washed with 100 μL PBS, after which 100 μL of DMSO was added and the plates were placed on a shaker for 10 min to allow for the dye to solubilise. The absorbance of each well was then read using the SpectraMax M3 spectrometer with λ ABS = 595 nm.
Reactive oxygen species
Carboxy-H 2 DCFDA dye was used for the detection of ROS. The dye was made up to a final concentration of 10 μM in sterile PBS. Before addition of PAMAM dendrimer, this dye was added to the cells and allowed to incubate for 1 h, after which the dye was removed, the cells were washed thrice with PBS and the medium containing PAMAM dendrimer was added. At the specified time points, the fluorescence was read by the SpectraMax M3 spectrometer with λ EX = 488 nm and λ EM = 535 nm.
Confocal laser scanning microscopy
Cells were plated onto MatTek 35-mm glass bottom dishes at a concentration of 20,000 cells/dish in DMEM F12 HAM (supplemented with 10 % FBS, 45 IU/mL penicillin, 45 IU/ mL streptomycin and 2 mM L-glutamine) and allowed to attach for 4 h, at which point the medium was removed and replaced with medium containing CellLight® Early Endosomes-RFP, BacMam 2.0 at a concentration of 20 particles per cell. Early endosome formation was tracked with the CellLight® Early Endosome-RFP kit, which transfects, into the cell, a version of Rab5a with a bound red fluorescent protein. The cells were allowed to incubate (37°C, 5 % CO 2 ) for 16 h to ensure transfection with the early endosome reagent. After this, the medium was removed and cells were washed twice with PBS. For cells being tested without BSO, a medium was added for 18 h (these samples are referred to as untreated cells/untreated controls in the text), while for cells being tested with BSO, a medium containing 200 μM BSO was added for 18 h. Cells were again washed with PBS and carboxy-H 2 DCFDA was added for 1 h (10 μM in 2 mL PBS), after which cells were again washed twice with PBS. PAMAM dendrimers were added at a concentration of 3.21 μM (G4) and 1 μM (G6), and cells were allowed to incubate for 3 h (G4) or 1 h (G6) and were then washed twice with PBS and imaged with the Zeiss LSM 510 confocal laser scanning microscope; 100 nm PSNP-NH 2 with attached green florescent protein was used as a positive control to ensure the CellLight® Early Endosomes-RFP was functioning as expected; the results of this test are available in the ESM section (Fig. S2) . Negative controls were also performed with cells which were not exposed to any nanoparticles, and little to no fluorescence was noted (data not shown). For ROS monitoring, doses and time points noted above were chosen based on the maximum responses previously reported in the literature [8] . All confocal images were analysed using ImageJ, and colocalisation studies were performed using Manders split coefficients calculated with the JaCoP plugin for ImageJ [42] .
Data analysis and statistics
Data analysis was performed using SigmaPlot™ v10.0 and fluorescence was calculated based on the values of BSO controls (which were unexposed to nanoparticles but had been treated with 200 μM BSO for 18 h). The cytotoxicity, GSH and ROS experiments were performed in 96-well microplates with six replicates per plate and each plate was repeated three times. Therefore, data points shown represent the mean of 18 points, with error bars representing ± the standard deviation (as calculated by SigmaPlot™ v10.0). Confocal images were taken on a Zeiss LSM 510 and processed using ImageJ software. Images were taken of eight cells/groups of cells and the images presented in the manuscript are representative of the sampled cell population.
Results
BSO treatment
While maximising the desired effect of the BSO on the cells, it is important that the viability of the cells is not affected. TTV showed a 40 % reduction in intracellular levels of GSH for the HaCaT cells upon 200 μM BSO exposure for 18 h (adapted from the methods of He et al. [24] ). These dose and time point were found to have a minimal impact on cellular viability as measured by the AB and MTT assays (data available in ESM, Fig. S3 ). Higher concentrations were found to have an effect on cellular viability, although a more pronounced effect was observed by CLSM, where signs of cellular stress were noted (data not shown). Therefore, 200 μM BSO exposure was chosen as optimal.
PAMAM G4 dendrimers
CLSM was employed as a way to examine the effect of BSO treatment on the cellular uptake mechanisms and subsequent oxidative stress. Early endosome formation was tracked with the CellLight® Early Endosome-RFP kit, and the formation of ROS was also tracked using the carboxy-H 2 DCFDA dye. Fluorescently labelled PSNP-NH 2 of 100 nm diameter was employed as positive controls, and the results are shown in the ESM, Fig. S2 . Figure 1 shows the HaCaT cells following the reported paradigm of PAMAM G4 endocytosis and subsequent ROS generation at the endosomal sites [6] [7] [8] [9] . Co-localisation (performed on the images in Fig. 1) shows that 91(±3)% of the generated ROS occurs in the neighbourhood of endosomes and that 71(±4)% of endosomal formation resulted in increases in ROS production (the other 30 % of endosomal activity is most likely due to endocytosis which would be routinely done by the cell and would not involve the dendrimers and therefore not produce ROS).
In contrast, Fig. 2 shows HaCaT cells which have been treated with BSO for 18 h prior to PAMAM G4 exposure (BSO was still present in the media upon exposure, to ensure conditions were consistent). In images (b) and (c), the intensity of the endosomal RFP and ROS dye has been significantly reduced. Again co-localisation analysis was performed (on images in Fig. 2 ) and showed that 30(±6)% of the generated ROS was happening around the endosomes and that 46(±14)% of endosomal formation resulted in increases in ROS production. Intensity analysis of the red fluorescent protein produced by endocytosis, on average, showed a reduction in intensity of 70(±3)% for cells treated with BSO.
Endosomal uptake was clearly reduced, although a decrease in the intensity of response of the ROS detection dye, carboxy-H 2 DCFDA, was also noted, prompting a quantitative analysis of the ROS contents of the HaCaT cells (Fig. 3) .
The analysis of ROS showed a net decrease at all doses tested; for clarity, only the dose dependence of the 24-h test has been shown and the full dataset is available in the ESM section (Fig. S4) . Over the dose range tested, the ROS response followed a monotonically decreasing trend. This result is again in contrast with previous observations, in which ROS levels were seen to increase above control levels in a dosedependent fashion, upon G4 dendrimer exposure [8] .
To examine how these changes in both endocytosis and ROS production affected the viability of the cell, AB and MTT assays were performed. HaCaT cells were exposed to 200 μM BSO for 18 h and subsequently exposed to varying concentrations of PAMAM G4 nanoparticles. Viability was measured at 6, 12, 24, 48 and 72 h (Fig. 4a, b) .
The AB assay shows little or no toxicity of PAMAM G4 at time points 6, 12 and 24 h, whereas the viability is reduced to 50 % at 48 h and 30 % at 72 h, for the higher dose exposures. In HaCaT cells which have not been treated with BSO, the EC 50 obtained from AB is around 10 μM at 24 h [7] , whereas in Fig. 4 , at the same time point, it is clear that there is no significant toxicity. The MTT results show a dramatically different dose-dependent cytotoxicity profile for the BSO-dosed cells compared to the un-dosed [7] . At 6-h exposure (Fig. 4b) , the viability is seen to be reduced to around 80 % over the entire dose range. However, at exposure times of 12, 24, 48 and 72 h, increases in viability are seen for the low-medium dose range. The effect is particularly pronounced at the 48-h time point, at which the recorded MTT response is ∼175 % of control, for an exposure dose of ∼1 μM. For doses of ∼2.6 μM and higher, the MTT assay response 
PAMAM G6 dendrimers
Analysis of uptake and ROS production was again carried out using CLSM (with the same method as the PAMAM G4) incorporating the carboxy-H 2 DCFDA dye and CellLight® Early Endosome-RFP kit (Figs. 5 and 6 ).
In the absence of BSO, PAMAM G6 exposure resulted in a strong red fluorescence indicating a high level of endocytosis, complemented by a strong green fluorescence indicating increased ROS production. Co-localisation analysis (of images in Fig. 5 ) found that 75(±2)% of the generated ROS occurred in the region of the endosomes and that 92(±1)% of endocytosis resulted in increases in ROS production. This strong level of co-localisation is indicative of the accepted paradigm of nanoparticle uptake by endocytosis and ROS production at the site of endosomes.
In comparison to exposure of PAMAM G6 in cells without BSO treatment (untreated cells), there is a sparsity of endosomal activity and oxidative stress response in cells which had been pre-treated with BSO for 18 h. Analysis (of the images in Fig. 6 ) show decreased levels of co-localisation between the ROS and endosomal formation: only 41(±18)% of ROS production was recorded in areas where endosomes had formed and 55(±10)% of endocytosis resulted in increases in ROS production. Intensity analysis of the red fluorescent protein produced by endocytosis, on average, showed a reduction in intensity of 61(±1)% for cells treated with BSO when compared to the untreated cells. Again, in light of the reduced ROS response, quantitative analysis using carboxy-H 2 DCFDA was performed (Fig. 7) . The dose response of the ROS generation shows similarities with the G4 in the overall progression of the response, pointing to a trend where increasing concentration leads to decreasing amounts of ROS, contrary to what has been observed in previous studies without BSO exposure [8] . As with the G4 analysis, for clarity, only one of the eight concentrations tested has been shown, and the full dataset is available in the ESM section (Fig. S5 ). At all doses tested, the ROS response followed the same trend as shown in Fig. 7 . To analyse the effect this had on viability, AB and MTT assays were performed (Fig. 8) .
The viability results of the PAMAM G6 dendrimers are similar to those observed in the G4 analysis. In Fig. 8 , for 6-and 12-h exposure, little toxicity is recorded by AB, although the response is significantly stronger at the later time points. The previously reported EC 50 obtained from the AB assay for PAMAM G6 dendrimers is in the range of 1-1.6 μM at 24 h [8] , which would appear to agree 
PAMAM G4-G6 comparative analysis
PAMAM nanoparticle toxicity is a generation-dependent process [7] [8] [9] ; therefore, a comparison of the response of BSOtreated cells to G4 and G6 dendrimer exposure was performed, to establish whether a similar generation dependence of the cellular responses is still evident.
The AB and MTT assays were compared for PAMAM G4 and G6 dendrimers, and the results are shown in Figs. 9 (AB) and 10 (MTT). For both dendrimers, approximately equivalent concentration ranges were used, although for the PAMAM G6 dendrimers, a slightly lower initial concentration was used due to the higher associated toxicity [7] [8] [9] [10] .
Little or no significant cytotoxicity was registered by the AB assay for either dendrimer at the 6-and 12-h time points. At 24 h, the higher toxicity associated with the G6 dendrimers becomes apparent, while the G4 still shows no significant change (ESM: Fig. S6c) . At 48 h (Fig. 9a) , the G4 dendrimers begin to elicit a significant toxic response, and finally, at 72 h (Fig. 9b) , the G4 toxic profile is beginning to match that of G6, although the reduction of viability occurs at lower doses for G6.
In the MTT, similar to AB response, no significant difference was seen in the 6-h analysis for the two dendrimers, . ROS is compared to BSO control which was set to equal 0 %. The X-axis is plotted logarithmically to allow for better visualisation of lower concentrations. Data points are the mean of 18 samples, with error bars showing (±) the standard deviation although differences become apparent at 12 h (ESM: Fig. S7b) , at which point the MTT response increases above that of controls for the G6 dendrimer. This increase in MTT response also occurs for the G4 dendrimers, although it is not manifested until the later time point of 48 h (Fig. 10a) . Similar to the AB response, cytotoxicity is registered by the MTT assay for both dendrimers beginning at 24 h; however, the AB only reaches about 50 % viability. At 48 and 72 h, a more complete toxic profile for both assays is seen and distinct generation dependence is observable, more consistent with that observed for untreated cells [7] .
To further investigate any generation dependence, the dose response of the ROS was compared for the G4 and the G6 (Fig. 11) . It is notable that the generation dependence of the trends is reversed in Fig. 11 where G4 elicits a more pronounced reduction in ROS levels than G6.
Discussion
The confocal images of Figs. 1 and 2 (PAMAM G4) and Figs. 5 and 6 (PAMAM G6) show that, for cells treated with 200 μM BSO for 18 h prior to PAMAM exposure, the rate of endocytosis has been markedly reduced. This reduction in endocytosis is accompanied by a similar reduction in intracellular ROS and a dramatic change in the responses of the cytotoxic assays. Nevertheless, the observed reduction of intracellular ROS and cytotoxic responses is systematically dependent on dendrimer exposure time, dose and generation, consistent with the intracellular action of dendritic nanoparticles.
The demonstrated mechanism of PAMAM dendrimer toxicity is one of endocytosis [8, 43, 44] , ROS production [7] [8] [9] 18] , subsequent endosomolysis, whereby the nanoparticle bursts out of the endosome/lysosome into the cytosol [19] , and localisation in the mitochondria [45] . Mukherjee and Byrne identified two apoptotic pathways, the death-receptor pathway (extrinsic, Fas-mediated FADD pathway [46] ) and the mitochondrial pathway (intrinsic, TNF-α mediated FADD [47] ) [10] . The former is initiated by the earlier stage ROS generation in the region of the endosomes, while the latter is initiated by the localisation of the dendrimers in the mitochondria. It has been proposed that the early stage ROS production is due to the action of NADPH oxidase [6] (producing superoxide anions (O 2 − ) [48] ) and the v-ATPase proton pump (providing protons [49] ), ultimately leading to production of H 2 O 2 [50] in and around the endosome. In cells (Fig. S6) treated with BSO, however, PAMAM dendrimers elicit a dramatically different cytotoxicity profile, as registered by the AB and MTT assays, compared to that of untreated cells [7, 8] .
Studies by Khalid et al. of cellular uptake of PPI dendrimers have demonstrated that, although the larger generation PPI dendrimers are endocytosed and elicit similar responses to PAMAM equivalents in HaCaT cells, for smaller generation PPI dendrimers, uptake by passive diffusion occurs, and when the dendrimers enter the cell in this way, they were observed to act as antioxidants and elicit a significantly reduced cytotoxic effect [18] . BSO exposure has been shown to permeabilise the cell membrane [28] , and as a result, it is proposed that the PAMAM G4 and G6 dendrimers are able to circumvent the endocytotic process, are uptaken by passive diffusion and, as PAMAM dendrimers, are similar in structure to PPI dendrimers and have comparable surface chemistry, similarly behaving as antioxidants in the cytosol, eliciting substantially reduced cytotoxic responses.
Alamar Blue is a non-specific assay and measures cellular viability based on the overall activity of the cytosolic environment [51] . The significant reduction, rather than expected increase, of toxicity as registered by this assay reflects the reduction in the endocytosis process (which initiates the Fasmediated FADD (death-receptor) apoptotic pathway), in favour of the passive diffusion of nanoparticles across the membrane, and consequent reduction in ROS generation in the region of endosomes. However, endocytosis is not fully eliminated for either generation, and therefore, the activation of the Fas mediated pathway, on a much reduced scale, would in part explain why the generation-dependent response is still observed for the PAMAMs.
The MTT assay measures mitochondrial activity as an indicator of cellular viability [52] [53] [54] , and in the case of the studies described here, the mitochondria are implicated in at least two different processes and changes in MTT responses reflect the dose and generation dependence of these processes at several time points. The first process is the loss of GSH from the cell, which has been shown to cause activation of mitochondrial signalling pathways and expression of genes associated with apoptosis, growth and differentiation [33, [38] [39] [40] . This overall increase in mitochondrial activity (observed in the low-dose regime) is seen as the initial increase in MTT values above controls, associated with dose-and generation-dependent decrease in ROS below controls, due to the antioxidant effect of the passively uptaken dendrimer nanoparticles.
The second effect gives rise to a sharp decrease in mitochondrial activity (observed in the higher dose regime), consistent with PAMAM dendrimer localisation and disruption of the mitochondria [7, 8] , initiating the mitochondrial apoptotic pathway, leading to cell death in a dose-dependent fashion, as observed for untreated cells [7, 8] . This process may be accelerated via the opening of the mitochondrial membrane (Fig. S7 ) Fig. 11 Dose-dependent generation of ROS in HaCaT cells (shown at 24 h for PAMAM G4 and G6). Data is compared to BSO control which was set to equal 0 %. The X-axis is plotted logarithmically to allow for better visualisation of lower concentrations. Data points are the mean of 18 samples, with error bars showing (±) the standard deviation permeability transition pore [30] [31] [32] . Whether passively diffused into the cell, or released into the cytosol by endosomolysis after endocytosis, the result of free PAMAM dendrimers in the cytosol and subsequent localisation to the mitochondria should be equivalent, both resulting in disruption of the mitochondria, a second phase increase in ROS within the cell, subsequent decay in the mitochondrial membrane potential and finally the initiation of a cascade leading to apoptosis [7] [8] [9] [10] . It should also be noted that in both cases the opening of the mitochondrial membrane transition pore occurs, either by the action of BSO [30] [31] [32] or due to the release of the endosomal/lysosomal contents causing intracellular release of Ca 2+ , leading to calcium-dependent opening of the pore [21] . This would, in both cases, facilitate the entry of the dendrimer to the mitochondria. As a result, in the high-dose regime, the observed toxic response of the BSO-treated cells, as registered by the MTT assay, is not very different to that observed for untreated cells.
The passive diffusion of dendrimers across the cell membrane is a size-dependent process [18] , and the generation dependence of the cellular responses to the two PAMAM dendrimer generations, G4 and G6 (Figs. 1, 2, 5 and 6), is consistent with a higher uptake rate for the G4 dendrimer than the G6. The greater reduction of intensity of Rab5a-RFP compared to controls (with no BSO treatment), for G4 dendrimers (70 %) compared to G6 (60 %), indicates a higher diffusion rate for G4 dendrimers, leaving fewer available for endocytosis. This further explains the higher rate of antioxidative activity exhibited by the G4 dendrimers when compared to G6 (Fig. 11) . Overall, it would appear that the membrane has become more permeable to an extent that favours passive uptake, although not completely eliminating active endocytosis.
Within the framework of adverse outcome pathways (AOPs), recently endorsed by the OECD [55, 56] as a method to simplify the representation of the mode of action of a toxicant or agonist, the generation of ROS can be considered the key molecular initiating event (MIE) of the AOP, which ultimately leads to the AO of loss of cell viability. The treatment with BSO causes a depletion of GSH, which would lead to the expectation of much increased ROS levels after endocytosis. However, that was not observed and the result of the reduction of intrinsic GSH levels by BSO treatment was predominantly the increased permeability of the cell membrane, resulting in an increased rate of uptake of the PAMAM dendrimers by passive diffusion, making it a favoured uptake mechanism, more so for the smaller G4 dendrimer than the larger G6. The co-existence of the parallel uptake mechanisms increases the complexity of any model to describe the in vitro system, although it could prove a useful model to develop networks of AOPs, initiated by different MIEs. However, to fully examine the effect of reduction of GSH in terms of decreased antioxidant activity alone, an assay which did not cause decrease of the permeabilisation of the cell membrane would be necessary.
Considering the potential for PAMAM dendrimers in nanomedical applications, it is important to note that, when diffused into the cell, the aminated surface chemistry of the dendrimers lend them antioxidant activity, similar to small molecular antioxidants, such as N-acetylcysteine (NAC) and NAC amide (NACA-a more bio-available version of NAC). NACA has been extensively studied as an antioxidant in the cell, due to its ability to diffuse across the membrane and the presence of a terminal proton donor group [57, 58] . Interestingly, it has also been shown to completely reverse the damage caused to the cell by depletion of GSH [59] [60] [61] . NACA, due to this strong antioxidant ability, has been proposed in the treatment of several disorders and diseases, such as HIV [62] , Alzheimer's and Parkinson's disease [60, 63] , cataract formation [59] , retinal degeneration [64] and essentially any disease where ROS is identified as the potential MIE ( [61] and references therein). If PAMAM dendrimers are seen to act in a similar way, it may potentially allow for their use in a plethora of different nanomedical applications. As a strategy for drug release, endosomolysis can be extremely disruptive to the cell [20] , and therefore, in the case of cationic nanoparticles for intracellular nanomedical applications, avoiding the process of endocytosis may be a valid strategy to pursue [22] . In terms of therapeutic applications, direct entry into the cytosol may be a more convenient route for drug or gene delivery.
Conclusions
Although PAMAM dendritic nanoparticles are known to elicit significant cytotoxic responses in vitro, the cellular response mechanisms can be notably altered by treatment of the cells with BSO. The treatment increases the cell membrane permeability, enabling uptake of the particles by passive diffusion, where after, they act as antioxidants in the cytosol, rather than producing oxidative stress in the region of endosomes. The ability to tune the cellular uptake mechanism allows direct entry into the cytosol and may have important implications for nanotoxicity as well as drug and gene delivery using nanovehicles.
